No benefit of endoscopic sphincterotomy before biliary placement of self-expandable metal stents for unresectable pancreatic cancer
ES is placed in malignant pancreatic cancer patients to prevent postprocedural esophageal cancer. It is not clear whether ES actually prevents pancreatitis or affects other adverse events. We conducted a noninferiority trial to see if the placement had any effect on cancer survival.
